NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said this week that it has established a grant program to award life science researchers more than $400,000 in RNA-interference reagents. The firm said that the Thermo Scientific Discovery Grant Program will include various siRNA, shRNA, and microRNA reagents from its Dharmacon and Open Biosystems RNAi technology portfolios.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.